Updated Feb. 20, 2013 at 12:45 p.m.

Premium Lock Chelsea fainting drug revived, 2Q drug application planned

Published: 2013-02-20 12:16:00
Updated: 2013-02-20 12:45:44

Chelsea Therapeutics logo Chelsea Therapeutics

Charlotte-based Chelsea Therapeutics said it has enough clinical data to resubmit a Northera drug application nearly a year after the the Food and Drug Administration declined to approve the drug. Chelsea said it plans to file a new drug application late in the second quarter....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Scroll